The Novel protein TSR2 inhibits the transcriptional activity of nuclear factor-κB and induces apoptosis

Molecular Biology

Volumn 45, Issue 3, 2011, Pages 451-457

  He, Hongjiang ^a   Zhu, Dan ^b   Sun, Ji ^a   Pei, Rong ^a   Jia, Shenshan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; laryngeal cancer; nuclear factor kappaB; TSR2

Indexed keywords

EID: 79958843095     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893311020099     Document Type: Article

References (25)

1. Sarkar F. H., Li Y. 2008. NF-kappaB: A potential target for cancer chemoprevention and therapy. Front. Biosci. 13, 2950-2959.
2. Herreros B., Rodriguez-Pinilla S. M., Pajares R., Martinez-Gonzalez M. A., Ramos R., Munoz I., Montes-Moreno S., Lozano M., Sanchez-Verde L., Roncador G., Sanchez-Beato M., de Otazu R. D., Perez-Guillermo M., Mestre M. J., Bellas C., Piris M. A. 2010. Proliferation centers in chronic lymphocytic leukemia: The niche where NF-kappaB activation takes place. Leukemia. 24, 872-876.
3. Pasparakis M. 2009. Regulation of tissue homeostasis by NF-kappaB signalling: Implications for inflammatory diseases. Nature Rev. Immunol. 9, 778-788.
4. Miller S. C., Huang R., Sakamuru S., Shukla S. J., Attene-Ramos M. S., Shinn P., van Leer D., Leister W., Austin C. P., Xia M. 2010. Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action. Biochem. Pharmacol. 79, 1272-1280.
5. Britanova L. V., Kuprash D. V. 2009. New putatative control elements in the promoter of the gene for the CXCL13 chemokine, a target of the alternative NF-kB pathway. Mol. Biol. (Moscow). 43, 604-611.
6. Baud V., Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. 2009. Nature Rev. Drug Discov. 8, 33-40.
7. Lerebours F., Vacher S., Andrieu C., Espie M., Marty M., Lidereau R., Bieche I. 2008. NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer. 8, 41.
8. Frasor J., Weaver A., Pradhan M., Dai Y., Miller L. D., Lin C. Y., Stanculescu A. 2009. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res. 69, 8918-8925.
9. Lee C. H., Jeon Y. T., Kim S. H., Song Y. S. 2007. NF-kappaB as a potential molecular target for cancer therapy. Biofactors. 29, 19-35.
10. Ban J. O., Yuk D. Y., Woo K. S., Kim T. M., Lee U. S., Jeong H. S., Kim D. J., Chung Y. B., Hwang B. Y., Oh K. W., Hong J. T. 2007. Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. J. Pharmacol. Sci. 104, 374-383.
11. Pandey M. K., Sung B., Kunnumakkara A. B., Sethi G., Chaturvedi M. M., Aggarwal B. B. 2008. Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 8, 5370-5379.
12. Kim H. J., Hawke N., Baldwin A. S. 2006. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ. 13, 738-747.
13. Li Z. W., Chen H., Campbell R. A., Bonavida B., Berenson J. R. 2008. NF-kappaB in the pathogenesis and treatment of multiple myeloma. Curr. Opin Hematol. 15, 391-399.
14. Baud V., Karin M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
15. Kirillova I., Chaisson M., Fausto N. 1999. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ. 10, 819-828.
16. Fadok V. A., Bratton D. L., Frasch S. C., Warner M. L., Henson P. M. 1998. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5, 551-562.
17. Lee S. H., Lee C. W., Lee J. W., Choi M. S., Son D. J., Chung Y. B., Lee C. K,. Oh K. W., Moon D. C., Kwon B. M., Hong J. T. 2005. Induction of apoptotic cell death by 2′-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-kappaB in TNF-alpha-treated SW620 colon cancer cells. Biochem. Pharmacol. 70, 1147-1157.
18. Royuela M., Rodriguez-Berriguete G., Fraile B., Paniagua R. 2008. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate. Histol. Histopathol. 23, 1279-1290.
19. Escarcega R. O., Fuentes-Alexandro S., Garcia-Carrasco M., Gatica A., Zamora A. 2007. The transcription factor nuclear factor-kappa B and cancer. Clin. Oncol. (R. Coll. Radiol.). 19, 154-161.
20. Hou M. F., Lin S. B., Yuan S. S., Tsai S. M., Wu S. H., Ou-Yang F., Hsieh J. S., Tsai K. B., Huang TJ., Tsai L. Y. 2003. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin. Chim. Acta. 334, 137-144.
21. Dai Y., Lawrence T. S., Xu L. 2009. Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am. J. Transl. Res. 1, 1-15.
22. Katsman A., Umezawa K., Bonavida B. 2009. Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. Curr. Pharm. Des. 15, 792-808.
23. Lin Y., Bai L., Chen W., Xu S. 2010. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin. Ther. Targets. 14, 45-55.
24. Morais C., Pat B., Gobe G., Johnson D. W., Healy H. 2006. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol. Dial. Transplant. 21, 3377-3388.
25. Morais C., Healy H., Johnson D. W., Gobe G. 2010. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma. Nephrol. Dial. Transplant. 25, 462-474.